08 Jan 2020 Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture Investors | News | Therapeutics
18 Oct 2019 Proposed Placing and Subscription to raise up to £9 million and Notice of General Meeting Investors
19 Sep 2019 Webinar: Affimer® anti-idiotypic affinity reagents for pharmacokinetic analysis of biotherapeutics Reagents & Diagnostics
29 Jul 2019 Avacta’s Chief Executive Officer to Present at the Solebury Trout European Biotech Investor Day in New York Investors